Indo-Bangla Pharmaceuticals Limited (DSE: IBP)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
9.70
-0.10 (-1.02%)
At close: Jan 23, 2025
-43.27%
Market Cap 1.15B
Revenue (ttm) 119.08M
Net Income (ttm) -44.98M
Shares Out 116.21M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend 0.01 (0.10%)
Ex-Dividend Date Dec 4, 2024
Volume 86,012
Average Volume 126,923
Open 9.80
Previous Close 9.80
Day's Range 9.70 - 9.90
52-Week Range 6.80 - 20.80
Beta 0.13
RSI 56.01
Earnings Date Jan 29, 2025

About DSE: IBP

Indo-Bangla Pharmaceuticals Limited engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally. Its principal products include analgesics and antipyretics, anthelmintic, anti-asthmatic, gastroprokinetic and antiemetic, antiprotozoal, non-hormone sex stimulant, non-steroidal, anti-inflammatory, steroids, and vitamins and minerals, as well as respiratory, cardiovascular, central nervous system, dermatology, and gastrointestinal categories. The company markets its products ... [Read more]

Industry Pharmaceutical Preparations
Founded 1954
Employees 152
Stock Exchange Dhaka Stock Exchange
Ticker Symbol IBP
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.